Mobile health technologies in an interventional hybrid study on actinic keratosis: Results from an early phase randomized controlled trial investigating the safety and efficacy of a cytosolic phospholipase A2 inhibitor gel in photodamaged skin

Hybrid trials are a new trend in dermatological research that leverage mobile health technologies to decentralize a subset of clinical trial elements and thereby reduce the number of in‐clinic visits. In a Phase I/IIa randomized controlled hybrid trial, the safety and efficacy of an anti‐proliferati...

Ausführliche Beschreibung